EGX
10.00 EGP
+15.50%From 3 to 6 months
Buy stock at the current price
June 16, 2025 at 9:57:13 AM
Medium
85.00%
15.00%
Nozha International Hospital has demonstrated consistent financial growth, with a 19.36% year-over-year revenue increase in FY2024, reaching EGP 432.42 million. The stock has shown a 31.86% rise over the past year, reflecting strong market performance. Additionally, the company's low debt-to-equity ratio of 0.06 indicates solid financial stability, making it a promising candidate for investors seeking growth in the healthcare sector.
Over the past year, NINH's stock has increased by 31.86%, outperforming many peers in the healthcare sector. The stock currently trades at EGP 8.66, with a 52-week range between EGP 5.95 and EGP 10.20.
The Egyptian healthcare sector is experiencing growth due to population expansion and increased demand for quality medical services. Government initiatives to enhance healthcare infrastructure further support the industry's development, providing a favorable environment for hospitals like Nozha International Hospital to thrive.
Nozha International Hospital operates in a competitive healthcare market but differentiates itself through a broad range of specialized services, including internal medicine, surgery, obstetrics and gynecology, pediatrics, psychiatry, orthopedics, ophthalmology, and physical therapy. Its comprehensive service offering positions it well to meet diverse patient needs.
Nozha International Hospital exhibits strong financial health, a diverse range of services, and operates in a growing healthcare market. These factors contribute to its positive growth outlook, making it a favorable investment opportunity.
- Significant revenue growth with a 19.36% year-over-year increase in FY2024.
- Strong market performance, with a 31.86% rise in stock price over the past year.
- Comprehensive range of specialized medical services catering to diverse patient needs.
- Favorable economic environment in Egypt's growing healthcare sector.
